Literature DB >> 12876666

Classification of cytotoxic T-cell and natural killer cell lymphomas.

Elaine S Jaffe1, Laszlo Krenacs, Mark Raffeld.   

Abstract

Mature or peripheral T-cell lymphomas are uncommon, accounting for only 10% to 15% of all non-Hodgkin's lymphomas. The classification of these neoplasms has been controversial. In contrast to B-cell lymphomas, cytologic features have not been useful in defining disease entities, and cytologic grade has not helped predict the clinical course. Similarly, many entities of T-cell or natural killer (NK) cell derivation do not have a specific immunophenotype. Clinical features are of major importance in defining T-cell and NK cell neoplasms, and in some cases the clinical syndrome, may be more important than the precise cell of origin. The majority of cytotoxic T-cell and NK cell lymphomas arise in extranodal sites. The expression of cytotoxic molecules in these lymphomas may predispose to apoptosis by tumor cells and normal bystander cells. Three major categories of extranodal T/NK cell tumors are recognized in the World Health Organization (WHO) classification: extranodal NK/T, nasal-type; enteropathy-type; and subcutaneous panniculitis-like. Epstein Barr virus (EBV) is closely linked to nasal NK/T-cell lymphoma, but shows geographic and racial variations in other subtypes. Tumors resembling the prototype of nasal NK/T-cell lymphoma occur in a variety of extranodal sites, and are referred to as nasal-type. Hepatosplenic T-cell lymphoma is a more systemic disease derived from functionally immature cytotoxic cells, usually gammadelta T-cell origin. Cytotoxic T-cell lymphomas of mature gammadelta T-cell origin most often arise in mucocutaneous sites, and may resemble the prototypes of extranodal T/NK cell lymphoma: nasal, enteropathy-associated, and panniculitis-like. Cytotoxic T/NK cell lymphomas occur with increased frequency in the setting of immune suppression, especially following organ transplantation. The nodal T-cell lymphoma most often exhibiting a cytotoxic immunophenotype is anaplastic large cell lymphoma (ALCL). Primary cutaneous ALCL frequently but not invariably expresses cytotoxic molecules. While the majority of extranodal neoplasms are derived from innate immune effector cells of NK cell and T-cell origin (gammadelta greater than alphabeta), most nodal cytotoxic T-cell lymphomas probably belong to the adaptive immune system. Studies of these neoplasms may assist in unraveling the diversity of their normal counterparts.

Entities:  

Mesh:

Year:  2003        PMID: 12876666     DOI: 10.1016/s0037-1963(03)00132-x

Source DB:  PubMed          Journal:  Semin Hematol        ISSN: 0037-1963            Impact factor:   3.851


  21 in total

1.  A phase 1/2 trial of arginine butyrate and ganciclovir in patients with Epstein-Barr virus-associated lymphoid malignancies.

Authors:  Susan P Perrine; Olivier Hermine; Trudy Small; Felipe Suarez; Richard O'Reilly; Farid Boulad; Joyce Fingeroth; Melissa Askin; Arthur Levy; Steven J Mentzer; Massimo Di Nicola; Alessandro M Gianni; Christoph Klein; Steven Horwitz; Douglas V Faller
Journal:  Blood       Date:  2006-11-21       Impact factor: 22.113

2.  Nonhepatosplenic γδ T-cell lymphomas represent a spectrum of aggressive cytotoxic T-cell lymphomas with a mainly extranodal presentation.

Authors:  Adriana Garcia-Herrera; Joo Y Song; Shih-Sung Chuang; Neus Villamor; Luis Colomo; Stefania Pittaluga; Tomas Alvaro; Maria Rozman; Jazmin de Anda Gonzalez; Ana Maria Arrunategui; Eva Fernandez; Elena Gonzalvo; Teresa Estrach; Dolors Colomer; Mark Raffeld; Philippe Gaulard; Elias Campo; Elaine S Jaffe; Antonio Martinez
Journal:  Am J Surg Pathol       Date:  2011-08       Impact factor: 6.394

3.  CD56-negative extranodal NK/T cell lymphoma should be regarded as a distinct subtype with poor prognosis.

Authors:  Liang Wang; Zhao Wang; Zhong-Jun Xia; Yue Lu; Hui-Qiang Huang; Yu-Jing Zhang
Journal:  Tumour Biol       Date:  2015-05-03

4.  Linkage of expression of chemokine receptors (CXCR3 and CCR4) and cytotoxic molecules in peripheral T cell lymphoma, not otherwise specified and ALK-negative anaplastic large cell lymphoma.

Authors:  Naoko Asano; Ritsuro Suzuki; Koichi Ohshima; Yoshitoyo Kagami; Fumihiro Ishida; Tadashi Yoshino; Hiroshi Ogawa; Yasuo Morishima; Shigeo Nakamura
Journal:  Int J Hematol       Date:  2010-03-09       Impact factor: 2.490

5.  CD56-Negative Extranodal NK/T-Cell Lymphoma, Nasal Type, with Extranasal Cutaneous Involvement.

Authors:  Hee Joo Kim; Soo Hee Kim; Sang Ho Oh
Journal:  Ann Dermatol       Date:  2015-10-02       Impact factor: 1.444

6.  [Peripheral NK/T-cell lymphoma].

Authors:  T Rüdiger; A Zettl; P Adam; I Bonzheim; E Geissinger; H K Müller-Hermelink
Journal:  Pathologe       Date:  2007-02       Impact factor: 1.011

7.  ALK Positive Anaplastic Large Cell Lymphoma Presenting as Extensive Bone Involvement.

Authors:  Smeeta Gajendra; Ritesh Sachdev; Lipika Lipi; Shalini Goel; Ruchira Misra
Journal:  J Clin Diagn Res       Date:  2015-01-01

8.  A rare pediatric case of a thymic cytotoxic and lymphoblastic T/NK cell lymphoma.

Authors:  Timo Gaiser; Wolfgang Haedicke; Maria R Becker
Journal:  Int J Clin Exp Pathol       Date:  2010-03-20

9.  Rare natural killer cell lymphoma found during surveillance endoscopy.

Authors:  Maqsood Khan; Srinadh Komanduri
Journal:  J Gastrointest Cancer       Date:  2009

10.  JAK3 deregulation by activating mutations confers invasive growth advantage in extranodal nasal-type natural killer cell lymphoma.

Authors:  A Bouchekioua; L Scourzic; O de Wever; Y Zhang; P Cervera; A Aline-Fardin; T Mercher; P Gaulard; R Nyga; D Jeziorowska; L Douay; W Vainchenker; F Louache; C Gespach; E Solary; P Coppo
Journal:  Leukemia       Date:  2013-05-21       Impact factor: 11.528

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.